Last Friday, the Health Evidence Review Commission approved Guideline 12, a measure they say will open up care for more cancer patients under the Oregon Health Plan. The new guidelines did away with a stipulation that restricted treatment for patients with less than two years to live. Still, there are those who oppose the measure, arguing that legislating cancer treatment based on things like age and life expectancy is illegal under the Affordable Care Act.
Will you or someone you know be affected by the new guidelines on cancer treatment? What’s been your experience with OHP?
- Ariel Smits: Medical Director, Health Evidence Review Commission
- James Gajewski: Oncologist, OHSU
- BJ Cavnor: Executive Director, Northwest Patient Education Network